Skip to main content
Erschienen in: Inflammation 4/2022

29.03.2022 | Original Article

The Integrated Analysis of Transcriptomics and Metabolomics Unveils the Therapeutical Effect of Asiatic Acid on Alcoholic Hepatitis in Rats

verfasst von: Siyun Chen, Yushen Huang, Hongmei Su, Wuchang Zhu, Yuanyuan Wei, Yan Long, Yanxia Shi, Jinbin Wei

Erschienen in: Inflammation | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

The present study was to investigate the therapeutical effects and mechanisms of Asiatic acid from Potentilla chinensis against alcoholic hepatitis. Rats were intragastrically fed with alcohol for 12 weeks to induce alcoholic hepatitis and then treated with various drugs for further 12 weeks. The results showed that Asiatic acid significantly alleviated liver injury caused by alcohol in rats, as evidenced by the improved histological changes and the lower levels of AST, ALT, and TBIL. Besides, Asiatic acid significantly enhanced the activity of ADH and ALDH, promoting alcohol metabolism. Asiatic acid suppressed CYP2E1 activity and NADP+/NADPH ratio, resulting in low ROS production. Further study revealed that Asiatic acid markedly reduced hepatocyte apoptosis by regulating the expression levels of apoptosis-related protein. Moreover, Asiatic acid could regulate the Nrf2 and NF-κB signaling pathway, attenuating oxidative stress and inflammation as a result. Interestingly, the comprehensive analysis of transcriptomics and metabolomics indicated that Asiatic acid inhibited the gene expression of Gpat3 and thereby affected the biosynthesis of the metabolites (1-acyl-Sn-glycerol-3-phosphocholine, phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine), regulating the glycerophospholipid metabolism pathway and ultimately ameliorating hepatocyte damage. In conclusion, this study demonstrates that Asiatic acid can ameliorate alcoholic hepatitis by modulating the NF-κB and Nrf2 signaling pathways and the glycerophospholipid metabolism pathway, which may be developed as a potential medicine for the treatment of alcoholic hepatitis.
Literatur
1.
Zurück zum Zitat Wan, Y., H. Wu, Y. Li, Z. Xu, J. Yang, C. Liu, Y. He, M. Wang, X. Wu, and Y. Zhang. 2020. viaTSG-6 Inhibits Oxidative Stress and Induces M2 Polarization of Hepatic Macrophages in Mice With Alcoholic Hepatitis Suppression of STAT3 Activation. Frontiers in pharmacology 11: 10.CrossRef Wan, Y., H. Wu, Y. Li, Z. Xu, J. Yang, C. Liu, Y. He, M. Wang, X. Wu, and Y. Zhang. 2020. viaTSG-6 Inhibits Oxidative Stress and Induces M2 Polarization of Hepatic Macrophages in Mice With Alcoholic Hepatitis Suppression of STAT3 Activation. Frontiers in pharmacology 11: 10.CrossRef
2.
Zurück zum Zitat Xiang, X., S. Hwang, D. Feng, V. Shah, and B. Gao. 2020. Interleukin-22 in alcoholic hepatitis and beyond. Hepatology international 14: 667–676.CrossRef Xiang, X., S. Hwang, D. Feng, V. Shah, and B. Gao. 2020. Interleukin-22 in alcoholic hepatitis and beyond. Hepatology international 14: 667–676.CrossRef
3.
Zurück zum Zitat Takeuchi, M., P. Vidigal, M. Guerra, M. Hundt, M. Robert, M. Olave-Martinez, S. Aoki, T. Khamphaya, R. Kersten, E. Kruglov, et al. 2021. Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis. Gut 70: 342–356.PubMed Takeuchi, M., P. Vidigal, M. Guerra, M. Hundt, M. Robert, M. Olave-Martinez, S. Aoki, T. Khamphaya, R. Kersten, E. Kruglov, et al. 2021. Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis. Gut 70: 342–356.PubMed
4.
Zurück zum Zitat Gala, K., and V. Vatsalya. 2020. Emerging noninvasive biomarkers, and medical management strategies for alcoholic hepatitis: present understanding and scope. Cells 9. Gala, K., and V. Vatsalya. 2020. Emerging noninvasive biomarkers, and medical management strategies for alcoholic hepatitis: present understanding and scope. Cells 9.
5.
Zurück zum Zitat Waleed, M., M. Abdallah, Y. Kuo, J. Arab, R. Wong, and A. Singal. 2020. Higher Frequency of Hospital-Acquired Infections but Similar In-Hospital Mortality Among Admissions With Alcoholic Hepatitis at Academic vs. Non-academic Centers. Frontiers in physiology 11: 594138. Waleed, M., M. Abdallah, Y. Kuo, J. Arab, R. Wong, and A. Singal. 2020. Higher Frequency of Hospital-Acquired Infections but Similar In-Hospital Mortality Among Admissions With Alcoholic Hepatitis at Academic vs. Non-academic Centers. Frontiers in physiology 11: 594138.
6.
Zurück zum Zitat Bieghs, V., and C. Trautwein. 2013. The innate immune response during liver inflammation and metabolic disease. Trends in immunology 34: 446–452.CrossRef Bieghs, V., and C. Trautwein. 2013. The innate immune response during liver inflammation and metabolic disease. Trends in immunology 34: 446–452.CrossRef
7.
Zurück zum Zitat Han, Y., B. Glueck, D. Shapiro, A. Miller, S. Roychowdhury, and G. Cresci. 2020. Dietary Synbiotic Supplementation Protects Barrier Integrity of Hepatocytes and Liver Sinusoidal Endothelium in a Mouse Model of Chronic-Binge Ethanol Exposure. Nutrients 12. Han, Y., B. Glueck, D. Shapiro, A. Miller, S. Roychowdhury, and G. Cresci. 2020. Dietary Synbiotic Supplementation Protects Barrier Integrity of Hepatocytes and Liver Sinusoidal Endothelium in a Mouse Model of Chronic-Binge Ethanol Exposure. Nutrients 12.
8.
Zurück zum Zitat Li, Y., Y. Zeng, Q. Huang, S. Wen, Y. Wei, Y. Chen, X. Zhang, F. Bai, Z. Lu, J. Wei, X. Lin. 2019. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 119: 109435. Li, Y., Y. Zeng, Q. Huang, S. Wen, Y. Wei, Y. Chen, X. Zhang, F. Bai, Z. Lu, J. Wei, X. Lin. 2019. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 119: 109435.
9.
Zurück zum Zitat Zheng, H., J. Wu, H. Huang, C. Meng, W. Li, T. Wei, and Z. Su. 2019. Metabolomics analysis of the protective effect of rubusoside on palmitic acid-induced lipotoxicity in INS-1 cells using UPLC-Q/TOF MS. Molecular omics 15: 222–232.CrossRef Zheng, H., J. Wu, H. Huang, C. Meng, W. Li, T. Wei, and Z. Su. 2019. Metabolomics analysis of the protective effect of rubusoside on palmitic acid-induced lipotoxicity in INS-1 cells using UPLC-Q/TOF MS. Molecular omics 15: 222–232.CrossRef
10.
Zurück zum Zitat Rachakonda, V., C. Gabbert, A. Raina, L. Bell, S. Cooper, S. Malik, J. Behari. 2014. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways. PloS one 9: e113860. Rachakonda, V., C. Gabbert, A. Raina, L. Bell, S. Cooper, S. Malik, J. Behari. 2014. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways. PloS one 9: e113860.
11.
Zurück zum Zitat Michelena, J., C. Alonso, I. Martínez-Arranz, J. Altamirano, R. Mayo, P. Sancho-Bru, R. Bataller, P. Ginès, A. Castro, and J. Caballería. 2019. Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis. Annals of hepatology 18: 144–154.CrossRef Michelena, J., C. Alonso, I. Martínez-Arranz, J. Altamirano, R. Mayo, P. Sancho-Bru, R. Bataller, P. Ginès, A. Castro, and J. Caballería. 2019. Metabolomics Discloses a New Non-invasive Method for the Diagnosis and Prognosis of Patients with Alcoholic Hepatitis. Annals of hepatology 18: 144–154.CrossRef
12.
Zurück zum Zitat Wang, D., L. Lao, X. Pang, Q. Qiao, L. Pang, Z. Feng, F. Bai, X. Sun, X. Lin, and J. Wei. 2018. Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism. International Immunopharmacology 65: 256–267.CrossRef Wang, D., L. Lao, X. Pang, Q. Qiao, L. Pang, Z. Feng, F. Bai, X. Sun, X. Lin, and J. Wei. 2018. Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism. International Immunopharmacology 65: 256–267.CrossRef
13.
Zurück zum Zitat Federico, A., M. Dallio, and C. Loguercio. 2017. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules (Basel, Switzerland) 22. Federico, A., M. Dallio, and C. Loguercio. 2017. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules (Basel, Switzerland) 22.
14.
Zurück zum Zitat Wei, J., Q. Huang, R. Huang, Y. Chen, S. Lv, L. Wei, C. Liang, S. Liang, L. Zhuo, and X. Lin. 2013. Asiatic acid from Potentilla chinensis attenuate ethanol-induced hepatic injury via suppression of oxidative stress and Kupffer cell activation. Biological pharmaceutical bulletin 36: 1980–1989.CrossRef Wei, J., Q. Huang, R. Huang, Y. Chen, S. Lv, L. Wei, C. Liang, S. Liang, L. Zhuo, and X. Lin. 2013. Asiatic acid from Potentilla chinensis attenuate ethanol-induced hepatic injury via suppression of oxidative stress and Kupffer cell activation. Biological pharmaceutical bulletin 36: 1980–1989.CrossRef
15.
Zurück zum Zitat Feng, Z., L. Pang, S. Chen, X. Pang, Y. Huang, Q. Qiao, Y. Wang, S. Vonglorkham, Q. Huang, X. Lin, and J. Wei. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice. International immunopharmacology 88: 107003. Feng, Z., L. Pang, S. Chen, X. Pang, Y. Huang, Q. Qiao, Y. Wang, S. Vonglorkham, Q. Huang, X. Lin, and J. Wei. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice. International immunopharmacology 88: 107003.
16.
Zurück zum Zitat Pang, X., Q. Qiao, S. Vonglorkham, Z. Feng, L. Pang, S. Chen, D. Wang, L. Lao, X. Lin, and J. Wei. 2020. Asiatic acid ameliorates acute hepatic injury by reducing endoplasmic reticulum stress and triggering hepatocyte autophagy. Biomed Pharmacother 129: 110375. Pang, X., Q. Qiao, S. Vonglorkham, Z. Feng, L. Pang, S. Chen, D. Wang, L. Lao, X. Lin, and J. Wei. 2020. Asiatic acid ameliorates acute hepatic injury by reducing endoplasmic reticulum stress and triggering hepatocyte autophagy. Biomed Pharmacother 129: 110375.
17.
Zurück zum Zitat Xiao, W., R.S. Wang, D.E. Handy, and J. Loscalzo. 2018. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. Antioxidants & Redox Signaling 28: 251–272.CrossRef Xiao, W., R.S. Wang, D.E. Handy, and J. Loscalzo. 2018. NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism. Antioxidants & Redox Signaling 28: 251–272.CrossRef
18.
Zurück zum Zitat Piszczatowska, K., D. Przybylska, E. Sikora, and G. Mosieniak. Inhibition of NADPH Oxidases Activity by Diphenyleneiodonium Chloride as a Mechanism of Senescence Induction in Human Cancer Cells. Antioxidants 9. Piszczatowska, K., D. Przybylska, E. Sikora, and G. Mosieniak. Inhibition of NADPH Oxidases Activity by Diphenyleneiodonium Chloride as a Mechanism of Senescence Induction in Human Cancer Cells. Antioxidants 9.
19.
Zurück zum Zitat Zhao, X., L. Gong, C. Wang, M. Liu, N. Hu, X. Dai, C. Peng, and Y. Li. 2021. Quercetin mitigates ethanol-induced hepatic steatosis in zebrafish via P2X7R-mediated PI3K/ Keap1/Nrf2 signaling pathway. J Ethnopharmacol 268: 113569. Zhao, X., L. Gong, C. Wang, M. Liu, N. Hu, X. Dai, C. Peng, and Y. Li. 2021. Quercetin mitigates ethanol-induced hepatic steatosis in zebrafish via P2X7R-mediated PI3K/ Keap1/Nrf2 signaling pathway. J Ethnopharmacol 268: 113569.
20.
Zurück zum Zitat Sehrawat, T., M. Liu, and V. Shah. 2020. The knowns and unknowns of treatment for alcoholic hepatitis. The lancet Gastroenterology hepatology international 5: 494–506.CrossRef Sehrawat, T., M. Liu, and V. Shah. 2020. The knowns and unknowns of treatment for alcoholic hepatitis. The lancet Gastroenterology hepatology international 5: 494–506.CrossRef
21.
Zurück zum Zitat Massey, V., A. Parrish, J. Argemi, M. Moreno, A. Mello, M. García-Rocha, J. Altamirano, G. Odena, L. Dubuquoy, A. Louvet, et al. 2021. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis. Gastroenterology 160: 1725-1740.e1722.CrossRef Massey, V., A. Parrish, J. Argemi, M. Moreno, A. Mello, M. García-Rocha, J. Altamirano, G. Odena, L. Dubuquoy, A. Louvet, et al. 2021. Integrated Multiomics Reveals Glucose Use Reprogramming and Identifies a Novel Hexokinase in Alcoholic Hepatitis. Gastroenterology 160: 1725-1740.e1722.CrossRef
22.
Zurück zum Zitat Ginting, C., I. Lister, E. Girsang, W. Widowati, D. Yusepany, A. Azizah, and H. Kusuma. 2021. Piper crocatumHepatotoxicity prevention in Acetaminophen-induced HepG2 cells by red betel ( Ruiz and Pav) extract from Indonesia via antioxidant, anti-inflammatory, and anti-necrotic. Heliyon 7: e05620. Ginting, C., I. Lister, E. Girsang, W. Widowati, D. Yusepany, A. Azizah, and H. Kusuma. 2021. Piper crocatumHepatotoxicity prevention in Acetaminophen-induced HepG2 cells by red betel ( Ruiz and Pav) extract from Indonesia via antioxidant, anti-inflammatory, and anti-necrotic. Heliyon 7: e05620.
23.
Zurück zum Zitat Wei, X., H. Wang, X. Sun, X. Huang, W. Xu, Y. Liang, L. Liu, S. Mo, X. Lin, and J. Lin. 2020. 4-hydroxy-2(3H)-benzoxazolone alleviates acetaminophen-induced hepatic injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways. American journal of translational research 12: 2169–2180.PubMedPubMedCentral Wei, X., H. Wang, X. Sun, X. Huang, W. Xu, Y. Liang, L. Liu, S. Mo, X. Lin, and J. Lin. 2020. 4-hydroxy-2(3H)-benzoxazolone alleviates acetaminophen-induced hepatic injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways. American journal of translational research 12: 2169–2180.PubMedPubMedCentral
24.
Zurück zum Zitat Sung, C.K., S.M. Kim, C.J. Oh, S.A. Yang, B.H. Han, and E.K. Mo. 2012. Taraxerone enhances alcohol oxidation via increases of alcohol dehyderogenase (ADH) and acetaldehyde dehydrogenase (ALDH) activities and gene expressions. Food Chemical Toxicology 50: 2508–2514.CrossRef Sung, C.K., S.M. Kim, C.J. Oh, S.A. Yang, B.H. Han, and E.K. Mo. 2012. Taraxerone enhances alcohol oxidation via increases of alcohol dehyderogenase (ADH) and acetaldehyde dehydrogenase (ALDH) activities and gene expressions. Food Chemical Toxicology 50: 2508–2514.CrossRef
25.
Zurück zum Zitat Yoo, Y., E. Jung, H. Kang, I. Choi, K. Choi, and E. Jeung. 2011. The sap of Acer okamotoanum decreases serum alcohol levels after acute ethanol ingestion in rats. International Journal of Molecular Medicine 28: 489–495.PubMed Yoo, Y., E. Jung, H. Kang, I. Choi, K. Choi, and E. Jeung. 2011. The sap of Acer okamotoanum decreases serum alcohol levels after acute ethanol ingestion in rats. International Journal of Molecular Medicine 28: 489–495.PubMed
26.
Zurück zum Zitat Yu, J., H. Zhu, M. Kindy, and S. Taheri. Cytochrome P450 CYP2E1 Suppression Ameliorates Cerebral Ischemia Reperfusion Injury. Antioxidants 10. Yu, J., H. Zhu, M. Kindy, and S. Taheri. Cytochrome P450 CYP2E1 Suppression Ameliorates Cerebral Ischemia Reperfusion Injury. Antioxidants 10.
27.
Zurück zum Zitat Hsu, M., S. Koike, A. Mello, L. Nagy, and F. Haj. 2020. Hepatic protein-tyrosine phosphatase 1B disruption and pharmacological inhibition attenuate ethanol-induced oxidative stress and ameliorate alcoholic liver disease in mice. Redox biology 36: 101658. Hsu, M., S. Koike, A. Mello, L. Nagy, and F. Haj. 2020. Hepatic protein-tyrosine phosphatase 1B disruption and pharmacological inhibition attenuate ethanol-induced oxidative stress and ameliorate alcoholic liver disease in mice. Redox biology 36: 101658.
28.
Zurück zum Zitat Chuang, C., C. Tsai, E. Lin, C. Huang, Y. Lin, C. Lan, and C. Huang. 2016. Heat-Killed Lactobacillus salivarius and Lactobacillus johnsonii Reduce Liver Injury Induced by Alcohol In Vitro and In Vivo. Molecules 21. Chuang, C., C. Tsai, E. Lin, C. Huang, Y. Lin, C. Lan, and C. Huang. 2016. Heat-Killed Lactobacillus salivarius and Lactobacillus johnsonii Reduce Liver Injury Induced by Alcohol In Vitro and In Vivo. Molecules 21.
29.
Zurück zum Zitat Robinson, K.E., and V.H. Shah. 2020. Pathogenesis and pathways: Nonalcoholic fatty liver disease & alcoholic liver disease. Translational Gastroenterology & Hepatology 5: 49–49.CrossRef Robinson, K.E., and V.H. Shah. 2020. Pathogenesis and pathways: Nonalcoholic fatty liver disease & alcoholic liver disease. Translational Gastroenterology & Hepatology 5: 49–49.CrossRef
30.
Zurück zum Zitat Shi, X., X. Jiang, B. Yuan, T. Liu, Y. Tang, Y. Che, Y. Shi, and Q. Ai. 2019. LINC01093Upregulation Protects against Alcoholic Hepatitis through Inhibition of NF-κB Signaling Pathway. Molecular Therapy-Nucleic Acids 17: 791–803.CrossRef Shi, X., X. Jiang, B. Yuan, T. Liu, Y. Tang, Y. Che, Y. Shi, and Q. Ai. 2019. LINC01093Upregulation Protects against Alcoholic Hepatitis through Inhibition of NF-κB Signaling Pathway. Molecular Therapy-Nucleic Acids 17: 791–803.CrossRef
31.
Zurück zum Zitat Sun, X., X. Huang, X. Zhu, L. Liu, S. Mo, H. Wang, X. Wei, S. Lu, F. Bai, and D. Wang. et al. HBOA ameliorates CCl-incuded liver fibrosis through inhibiting TGF-β1/Smads, NF-κB and ERK signaling pathways. Biomed Pharmacother 115: 108901. Sun, X., X. Huang, X. Zhu, L. Liu, S. Mo, H. Wang, X. Wei, S. Lu, F. Bai, and D. Wang. et al. HBOA ameliorates CCl-incuded liver fibrosis through inhibiting TGF-β1/Smads, NF-κB and ERK signaling pathways. Biomed Pharmacother 115: 108901.
32.
Zurück zum Zitat Li, P., D. Bing, X. Wang, J. Chen, Z. Du, Y. Sun, F. Qi, and H. Chu. New Target of Oxidative Stress Regulation in Cochleae: Alternative Splicing of the p62/Sqstm1 Gene. Journal of molecular neuroscience : MN 2022. Li, P., D. Bing, X. Wang, J. Chen, Z. Du, Y. Sun, F. Qi, and H. Chu. New Target of Oxidative Stress Regulation in Cochleae: Alternative Splicing of the p62/Sqstm1 Gene. Journal of molecular neuroscience : MN 2022.
33.
Zurück zum Zitat Xu, L., B. Zhao, S. Sun, S. Yu, Y. Wang, R. Ji, Z. Yang, L. Ma, Y. Yao, Y. Chen, et al. 2020. High-dose vitamin C alleviates pancreatic injury via the NRF2/NQO1/HO-1 pathway in a rat model of severe acute pancreatitis. Annals of translational medicine 8: 852.CrossRef Xu, L., B. Zhao, S. Sun, S. Yu, Y. Wang, R. Ji, Z. Yang, L. Ma, Y. Yao, Y. Chen, et al. 2020. High-dose vitamin C alleviates pancreatic injury via the NRF2/NQO1/HO-1 pathway in a rat model of severe acute pancreatitis. Annals of translational medicine 8: 852.CrossRef
34.
Zurück zum Zitat Wang, K., X. Zheng, Z. Pan, W. Yao, X. Gao, X. Wang, and X. Ding. 2020. Icariin Prevents Extracellular Matrix Accumulation and Ameliorates Experimental Diabetic Kidney Disease by Inhibiting Oxidative Stress via GPER Mediated p62-Dependent Keap1 Degradation and Nrf2 Activation. Frontiers in cell developmental biology 8: 559.CrossRef Wang, K., X. Zheng, Z. Pan, W. Yao, X. Gao, X. Wang, and X. Ding. 2020. Icariin Prevents Extracellular Matrix Accumulation and Ameliorates Experimental Diabetic Kidney Disease by Inhibiting Oxidative Stress via GPER Mediated p62-Dependent Keap1 Degradation and Nrf2 Activation. Frontiers in cell developmental biology 8: 559.CrossRef
35.
Zurück zum Zitat Dkhil, M., A. Abdel Moneim, T. Hafez, M. Mubaraki, W. Mohamed, F. Thagfan, S. and Al-Quraishy. 2019. Myristica fragrans Kernels Prevent Paracetamol-Induced Hepatotoxicity by Inducing Anti-Apoptotic Genes and Nrf2/HO-1 Pathway. Int J Mol Sci 20. Dkhil, M., A. Abdel Moneim, T. Hafez, M. Mubaraki, W. Mohamed, F. Thagfan, S. and Al-Quraishy. 2019. Myristica fragrans Kernels Prevent Paracetamol-Induced Hepatotoxicity by Inducing Anti-Apoptotic Genes and Nrf2/HO-1 Pathway. Int J Mol Sci 20.
36.
Zurück zum Zitat Zhuang, L., W. Ding, Q. Zhang, W. Ding, X. Xu, X. Yu, and D. Xi. 2021. TGR5 Attenuated Liver Ischemia-Reperfusion Injury by Activating the Keap1-Nrf2 Signaling Pathway in Mice. Inflammation 44: 859–872.CrossRef Zhuang, L., W. Ding, Q. Zhang, W. Ding, X. Xu, X. Yu, and D. Xi. 2021. TGR5 Attenuated Liver Ischemia-Reperfusion Injury by Activating the Keap1-Nrf2 Signaling Pathway in Mice. Inflammation 44: 859–872.CrossRef
37.
Zurück zum Zitat Zhou, C., H. Jia, Y. Liu, M. Yu, X. Chang, Y. Ba, and Z. Zou. 2016. Metabolism of glycerophospholipid, bile acid and retinol is correlated with the early outcomes of autoimmune hepatitis. Molecular bioSystems 12: 1574–1585.CrossRef Zhou, C., H. Jia, Y. Liu, M. Yu, X. Chang, Y. Ba, and Z. Zou. 2016. Metabolism of glycerophospholipid, bile acid and retinol is correlated with the early outcomes of autoimmune hepatitis. Molecular bioSystems 12: 1574–1585.CrossRef
38.
Zurück zum Zitat Miura, H., H. Mizuguchi, M. Amano-Iwashita, R. Maeda-Kogure, A. Negishi, A. Sakai, T. Toyama, H. Kawai, A. Mitsumoto, and N. Kudo. 2021. Clofibric acid increases molecular species of phosphatidylethanolamine containing arachidonic acid for biogenesis of peroxisomal membranes in peroxisome proliferation in the liver. Biochimica et biophysica acta Molecular and cell biology of lipids 1866: 158963. Miura, H., H. Mizuguchi, M. Amano-Iwashita, R. Maeda-Kogure, A. Negishi, A. Sakai, T. Toyama, H. Kawai, A. Mitsumoto, and N. Kudo. 2021. Clofibric acid increases molecular species of phosphatidylethanolamine containing arachidonic acid for biogenesis of peroxisomal membranes in peroxisome proliferation in the liver. Biochimica et biophysica acta Molecular and cell biology of lipids 1866: 158963.
39.
Zurück zum Zitat Hänninen, S., P. Somerharju, and M. Hermansson. Metabolic Heavy Isotope Labeling to Study Glycerophospholipid Homeostasis of Cultured Cells. Bio-protocol 7: e2268. Hänninen, S., P. Somerharju, and M. Hermansson. Metabolic Heavy Isotope Labeling to Study Glycerophospholipid Homeostasis of Cultured Cells. Bio-protocol 7: e2268.
40.
Zurück zum Zitat Lenoir, G., J. D'Ambrosio, T. Dieudonné, A. Čopič. 2021. Transport Pathways That Contribute to the Cellular Distribution of Phosphatidylserine. Frontiers in cell and developmental biology 9: 737907. Lenoir, G., J. D'Ambrosio, T. Dieudonné, A. Čopič. 2021. Transport Pathways That Contribute to the Cellular Distribution of Phosphatidylserine. Frontiers in cell and developmental biology 9: 737907.
Metadaten
Titel
The Integrated Analysis of Transcriptomics and Metabolomics Unveils the Therapeutical Effect of Asiatic Acid on Alcoholic Hepatitis in Rats
verfasst von
Siyun Chen
Yushen Huang
Hongmei Su
Wuchang Zhu
Yuanyuan Wei
Yan Long
Yanxia Shi
Jinbin Wei
Publikationsdatum
29.03.2022
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 4/2022
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-022-01660-x

Weitere Artikel der Ausgabe 4/2022

Inflammation 4/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.